Binding of retelliptine, a new antitumoral agent, to serum proteins and erythrocytes.
Maulard
C
C
Laboratoire de Pharmacocinétique, Institut Curie, Paris, France.
Urien
S
S
Bastian
G
G
Tillement
J P
JP
D000470:Alkaloids / Q000378:metabolism*; D000970:Antineoplastic Agents / Q000378:metabolism*; D001798:Blood Proteins / Q000378:metabolism*; D004611:Ellipticines / Q000378:metabolism*; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D066298:In Vitro Techniques; D011485:Protein Binding
D000470:Alkaloids; D000970:Antineoplastic Agents; D001798:Blood Proteins; D004611:Ellipticines; C046349:retelliptine